The Current Update of Vaccines for SARS-CoV-2
More details
Hide details
Department of Radiology, Haiphong University of Medicine and Pharmacy, Hai Phong City, VIETNAM
Department of Radiology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, VIETNAM
Department of Radiology, Children’s Hospital 2, Ho Chi Minh City, VIETNAM
Department of Radiology, Hanoi Medical University, Ha Noi, VIETNAM
Department of Radiology, Bach Mai Hospital, Ha Noi, VIETNAM
Online publication date: 2020-05-02
Publication date: 2020-05-02
Electron J Gen Med 2020;17(5):em248
Late 2019 witnessed the appearance of coronavirus disease 2019 (COVID-19) outbreak triggered by a new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 spread across China from Wuhan and has been circulated to a broader variety of countries. Seeing that COVID-19 has caused tremendous human casualties posing a global danger, an awareness of the current situation and the strategies to curtail the spread of the virus are desperately required. As the most natural way to preserve public wellbeing, preventive and therapeutic vaccinations must have essential roles. Large organizations and companies have started implementing SARS-CoV-2 preventive vaccinations. Hence, in this study, we aimed to update the vaccine evolution for SARS-CoV-2.
Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;26;382(13):1199-207. PMid:31995857.
Cakir Z, Savas HB. A Mathematical Modelling Approach in the Spread of the Novel 2019 Coronavirus SARS-CoV-2 (COVID-19) Pandemic. Electron J Gen Med. 2020;17(4):em205.
Gondauri D, Mikautadze E, Batiashvili M. Research on COVID-19 Virus Spreading Statistics based on the Examples of the Cases from Different Countries. Electron J Gen Med. 2020;17(4):em209.
World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available at: use/who-china-joint-mission-on-covid-19-final-report.pdf (Accessed 14 April 2020).
Minh Duc N, Duc Ha H, Anh Tuan T, Lien Bang MT, Hong Duc P, Minh Thong P. From First COVID-19 Case to Current Outbreak: A Vietnamese Report. Electron J Gen Med. 2020;17(4):em208.
3D medical animation coronavirus structure. Available at: https://www.scientificanimatio... (Accessed 20 April 2020).
Dunant R. COVID-19 Outbreak World Map per Capita. Available at (Accessed 20 April 2020).
Abdulamir AS, Hafidh RR. The Possible Immunological Pathways for the Variable Immunopathogenesis of COVID— 19 Infections among Healthy Adults, Elderly and Children. Electron J Gen Med. 2020;17(4):em202.
Wu C, Liu Y, Yang Y, Zhang P, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. 2020. PMCid:PMC7102550.
Wrapp D, Wang N, Corbett KS, Goldsmith JA, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260-3. PMID:32075877 PMCid:PMC7164637.
Aljofan M, Gaipov A. Chloroquine and COVID-19: A Light at the End of the Tunnel, or is it Another Train?. Electron J Gen Med. 2020;17(4):em207.
BioSpace. Codagenix and Serum Institute of India Initiate Co-Development of a Scalable, Live-Attenuated Vaccine Against the 2019 Novel Coronavirus, COVID-19. Available at: (Accessed 14 April 2020).
Our Efforts to Develop a Vaccine and Identify Therapies for COVID-19. Available at: (Accessed 14 April 2020).
A Study of a Candidate COVID-19 vaccine (COV001). Available at: (Accessed 14 April 2020).
Inovio Pharmaceuticals. Inovio Collaborating With Beijing Advaccine To Advance INO-4800 Vaccine Against New Coronavirus In China. Available at: (Accessed 14 April 2020).
Inside the Company That’s Hot-wiring Vaccine Research in the Race to Combat the Coronavirus. Available at: (Accessed 14 April 2020).
Smith J. CureVac bids to develop first mRNA coronavirus vaccine. 2020. Available at: (Accessed 14 April 2020).
Jiang S, Bottazzi ME, Du L, Lustigman S, et al. Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome. Expert Rev Vaccines. 2012;11(12):1405-13. PMid:23252385 PMCid: PMC3586247.
Mukherjee S. The first coronavirus drug candidate is set for testing in China. Fortune. 2020. Available at: (Accessed 14 April 2020).
Hennessy J. Australia’s been asked to make a coronavirus vaccine at ‘unprecedented speed’. Science Alert. 2020. Available at: (Accessed 14 April 2020).
Clover Biopharmaceuticals. Clover initiates development of recombinant subunit-trimer vaccine for Wuhan coronavirus (2019-nCoV). Available at: (Accessed 14 April 2020).
Pharmaceutical Technology N. Coronavirus: Vir Biotechnology and Novavax announce vaccine plans. Available at: https://www.pharmaceutical-tec... (Accessed 14 April 2020).
Vaxart. Vaxart Announces Initiation of Coronavirus Vaccine Program. 2020. Available at: (Accessed 14 April 2020).